Abstract:Core-shell nanostructures are powerful platforms for the development of novel nanoscale drug delivery systems with sustained drug release profiles. Coaxial electrospinning is facile and convenient for creating medicated core-shell nanostructures with elaborate designs with which the sustained-release behaviors of drug molecules can be intentionally adjusted. With resveratrol (RES) as a model for a poorly water-soluble drug and cellulose acetate (CA) and PVP as polymeric carriers, a brand-new electrospun core-shell nanostructure was fabricated in this study. The guest RES and the host CA molecules were designed to have a reverse gradient distribution within the core-shell nanostructures. Scanning electron microscope and transmission electron microscope evaluations verified that these nanofibers had linear morphologies, without beads or spindles, and an obvious core-shell double-chamber structure. The X-ray diffraction patterns and Fourier transform infrared spectroscopic results indicated that the involved components were highly compatible and presented in an amorphous molecular distribution state. In vitro dissolution tests verified that the new core-shell structures were able to prevent the initial burst release, extend the continuous-release time period, and reduce the negative tailing-off release effect, thus ensuring a better sustained-release profile than the traditional blended drug-loaded nanofibers. The mechanism underlying the influence of the new core-shell structure with an RES/CA reverse gradient distribution on the behaviors of RES release is proposed. Based on this proof-of-concept demonstration, a series of advanced functional nanomaterials can be similarly developed based on the gradient distributions of functional molecules within electrospun multi-chamber nanostructures.

A novel controlled release drug delivery system for multiple drugs based on electrospun nanofibers containing nanoparticles.

Development of Random and Ordered Composite Fiber Hybrid Technologies for Controlled Release Functions

A Novel Approach for Tailored Medicines: Direct Writing of Janus Fibers

Novel Controlled Drug Delivery System for Multiple Drugs Based on Electrospun Nanofibers Containing Nanomicelles

Potential of alginate fibers incorporated with drug-loaded nanocapsules as drug delivery systems

Electrospun composite nanofibers containing nanoparticles for the programmable release of dual drugs

Electrospun micelles/drug-loaded nanofibers for time-programmed multi-agent release.

A novel multiple drug release system in vitro based on adjusting swelling core of emulsion electrospun nanofibers with core-sheath structure.

Electrospun Micelles/Drug‐Loaded Nanofibers for Time‐Programmed Multi‐Agent Release

Fabrication of Core–shell Micro/nanoparticles for Programmable Dual Drug Release by Emulsion Electrospraying

Electrospinning of Biomacromolecules for Controlled Drug Release

Nanofiber Prepared by Intermittent Electrospun as Controlled Drug Delivery

Electrospun Fibre Composite for Controlled Drug Release

Controlled release of liposome-encapsulated Naproxen from core-sheath electrospun nanofibers.

Preparation and Characterization of Electrospun PLGA-SF Nanofibers As a Potential Drug Delivery System

Electrospun Fibers with Blank Surface and Inner Drug Gradient for Improving Sustained Release.

Electrospun quad-axial nanofibers for controlled and sustained drug delivery

Electrospun Poly (Ɛ-Caprolactone)/silk Fibroin Core-Sheath Nanofibers and Their Potential Applications in Tissue Engineering and Drug Release

Reverse Gradient Distributions of Drug and Polymer Molecules within Electrospun Core-Shell Nanofibers for Sustained Release

Controlled Release of Multiple Hydrophilic and Hydrophobic Drugs and in vitro Cytotoxicity of Electrospun Poly(lactic-co-glycolic acid)/ZnO Nanofibers Encapsulated with Dual Drugs

Controlled Dual Drug Release and in Vitro Cytotoxicity of Electrospun Poly(Lactic-Co-Glycolic Acid) Nanofibers Encapsulated with Micelles